Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis

Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people i...

Full description

Bibliographic Details
Main Authors: O. S. Mikhaylova, A. V. Krikova
Format: Article
Language:Russian
Published: IRBIS LLC 2022-07-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/693
_version_ 1797878892849004544
author O. S. Mikhaylova
A. V. Krikova
author_facet O. S. Mikhaylova
A. V. Krikova
author_sort O. S. Mikhaylova
collection DOAJ
description Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people in 2018 to 5,136 thousand in 2019. A growth in the number of cases resulted in an increase in the demand for drugs for the treatment of cardiovascular diseases.Objective: to perform a pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents by COI-analysis.Material and methods. The source of information for COI-analysis was the real clinical practice – medical records of sick children and adolescents. A pharmacoeconomic study using COI-analysis was carried out at the inpatient and outpatient stages of care and included the calculation of direct medical costs (the costs of laboratory, instrumental medical services, non-drug and drug antihypertensive therapy). The study included 102 children diagnosed with arterial hypertension. The average stay of patients in the hospital was 10 (10.4±0.35) bed-days and treatment on an outpatient basis varied from 3 months to 1 year.Results. The leading place in the structure of costs for antihypertensive therapy is occupied by the beta-blockers pharmacological group (35%). The total cost of arterial hypertension in children and adolescents in inpatient and outpatient settings was 4,459.00 and 29,638.90 rubles, respectively.Conclusion. The COI-analysis of arterial hypertension confirms the need for timely diagnosis and treatment and preventive measures for high blood pressure in children and adolescents to reduce the development of risk factors for such serious cardiovascular complications as stroke and myocardial infarction in adulthood, the treatment of which requires large cash costs.
first_indexed 2024-04-10T02:39:15Z
format Article
id doaj.art-a418bdb7f011477cba24bba3a80cf1f8
institution Directory Open Access Journal
issn 2070-4909
2070-4933
language Russian
last_indexed 2024-04-10T02:39:15Z
publishDate 2022-07-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj.art-a418bdb7f011477cba24bba3a80cf1f82023-03-13T07:48:18ZrusIRBIS LLCФармакоэкономика2070-49092070-49332022-07-0115219920810.17749/2070-4909/farmakoekonomika.2022.123391Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysisO. S. Mikhaylova0A. V. Krikova1Smolensk State Medical UniversitySmolensk State Medical UniversityBackground. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people in 2018 to 5,136 thousand in 2019. A growth in the number of cases resulted in an increase in the demand for drugs for the treatment of cardiovascular diseases.Objective: to perform a pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents by COI-analysis.Material and methods. The source of information for COI-analysis was the real clinical practice – medical records of sick children and adolescents. A pharmacoeconomic study using COI-analysis was carried out at the inpatient and outpatient stages of care and included the calculation of direct medical costs (the costs of laboratory, instrumental medical services, non-drug and drug antihypertensive therapy). The study included 102 children diagnosed with arterial hypertension. The average stay of patients in the hospital was 10 (10.4±0.35) bed-days and treatment on an outpatient basis varied from 3 months to 1 year.Results. The leading place in the structure of costs for antihypertensive therapy is occupied by the beta-blockers pharmacological group (35%). The total cost of arterial hypertension in children and adolescents in inpatient and outpatient settings was 4,459.00 and 29,638.90 rubles, respectively.Conclusion. The COI-analysis of arterial hypertension confirms the need for timely diagnosis and treatment and preventive measures for high blood pressure in children and adolescents to reduce the development of risk factors for such serious cardiovascular complications as stroke and myocardial infarction in adulthood, the treatment of which requires large cash costs.https://www.pharmacoeconomics.ru/jour/article/view/693pharmacoeconomicscost-of-illness analysisarterial hypertensionchildren and adolescentsantihypertensive therapy
spellingShingle O. S. Mikhaylova
A. V. Krikova
Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
Фармакоэкономика
pharmacoeconomics
cost-of-illness analysis
arterial hypertension
children and adolescents
antihypertensive therapy
title Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
title_full Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
title_fullStr Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
title_full_unstemmed Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
title_short Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
title_sort pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost of illness analysis
topic pharmacoeconomics
cost-of-illness analysis
arterial hypertension
children and adolescents
antihypertensive therapy
url https://www.pharmacoeconomics.ru/jour/article/view/693
work_keys_str_mv AT osmikhaylova pharmacoeconomicstudyofthetreatmentofarterialhypertensioninchildrenandadolescentsusingcostofillnessanalysis
AT avkrikova pharmacoeconomicstudyofthetreatmentofarterialhypertensioninchildrenandadolescentsusingcostofillnessanalysis